What is MariMed Price-to-Operating-Cash-Flow?
As of today (2024-04-29), MariMed's share price is $0.2666.
MariMed's Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Dec. 2023 was $0.02. Hence, MariMed's Price-to-Operating-Cash-Flow Ratio for today is 12.70.
The historical rank and industry rank for MariMed's Price-to-Operating-Cash-Flow or its related term are showing as below:
MRMD'
s Price-to-Operating-Cash-Flow Range Over the Past 10 Years
Min: 4.65 Med: 21.75 Max: 638
Current: 12.7
During the past 13 years, MariMed's highest Price-to-Operating-Cash-Flow Ratio was 638.00. The lowest was 4.65. And the median was 21.75.
MariMed's Cash Flow from Operations per share for the
three
months ended in Dec. 2023 was $0.01.
Its Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Dec. 2023 was $0.02.
During the past 12 months, the average Operating Cash Flow per Share Growth Rate of MariMed was 15.80% per year.
During the past 3 years, the average Operating Cash Flow per Share Growth Rate was 30.10% per year.
During the past 13 years, MariMed's highest 3-Year average Operating Cash Flow per Share Growth Rate was 69.60% per year. The lowest was -207.20% per year. And the median was -10.15% per year.
MariMed Price-to-Operating-Cash-Flow Historical Data
The historical data trend for MariMed's Price-to-Operating-Cash-Flow can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
MariMed Price-to-Operating-Cash-Flow Chart
|
MariMed Annual Data
|
|
Trend |
Dec14 |
Dec15 |
Dec16 |
Dec17 |
Dec18 |
Dec19 |
Dec20 |
Dec21 |
Dec22 |
Dec23 |
| Price-to-Operating-Cash-Flow |
|
Get a 7-Day Free Trial
|
|
|
- |
47.00 |
9.01 |
18.74 |
12.49 |
|
MariMed Quarterly Data
|
|
Mar19 |
Jun19 |
Sep19 |
Dec19 |
Mar20 |
Jun20 |
Sep20 |
Dec20 |
Mar21 |
Jun21 |
Sep21 |
Dec21 |
Mar22 |
Jun22 |
Sep22 |
Dec22 |
Mar23 |
Jun23 |
Sep23 |
Dec23 |
| Price-to-Operating-Cash-Flow |
Get a 7-Day Free Trial
|
|
|
|
|
|
|
|
|
|
|
|
|
18.74 |
- |
82.00 |
25.62 |
12.49 |
Competitive Comparison of MariMed's Price-to-Operating-Cash-Flow
For the Drug Manufacturers - Specialty & Generic subindustry, MariMed's Price-to-Operating-Cash-Flow, along with its competitors' market caps and Price-to-Operating-Cash-Flow data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
MariMed's Price-to-Operating-Cash-Flow Distribution in the Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, MariMed's Price-to-Operating-Cash-Flow distribution charts can be found below:
* The bar in red indicates where MariMed's Price-to-Operating-Cash-Flow falls into.
MariMed Price-to-Operating-Cash-Flow Calculation
MariMed's Price-to-Operating-Cash-Flow ratio for today is calculated as
| Price-to-Operating-Cash-Flow Ratio | = | Share Price | / | Cash Flow from Operations per share (TTM) |
| = | 0.2666 | / | 0.021 |
| = | 12.70 |
MariMed's Share Price of today is $0.2666.
MariMed's Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.02.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Note: Cash Flow from Operations per share is calculated as Cash Flow from Operations divided by Shares Outstanding (Diluted Average).
It can also be calculated from the numbers for the whole company:
MariMed (MariMed) Business Description
Traded in Other Exchanges
Address
10 Oceana Way, Floor 2, Norwood, MA, USA, 02062
MariMed Inc is a multi-state operator in the United States cannabis industry. It develops, operates, manages, and optimizes regulatory-compliant facilities for the cultivation, production, and dispensing of medical and adult-use cannabis. MariMed also licenses its proprietary brands of cannabis products along with other top brands in domestic markets Sources of revenue are comprised of Product sales (retail and wholesale), Real estate rental income, Supply procurement, Management fees, and Licensing fees.
Executives
| Jon R Levine |
10 percent owner |
C/O MARIMED INC., 10 OCEANA WAY, NORWOOD MA 02062 |
| Timothy Shaw |
officer: Chief Operating Officer |
C/O MARIMED INC, 10 OCEANA WAY, NORWOOD MA 02062 |
| Kathleen Tucker |
director |
C/O 10 OCEANA WAY, 2ND FLOOR, NORWOOD MA 02062 |
| Susan M. Villare |
officer: Chief Financial Officer |
C/O MARIMED INC., 10 OCEANA WAY, NORWOOD MA 02062 |
| Selhub Eva M.d. |
director |
C/O MARIMED INC., 10 OCEANA WAY, NORWOOD MA 02062 |
| David R Allen |
director |
C/O CONVERTED ORGANICS INC., 7A COMMERCIAL WHARF WEST, BOSTON MA 02110 |
| Thomas Kidrin |
director |
11 ROYAL ROAD, BROOKLINE MA 02445 |
| Edward J Gildea |
director |
C/O CONVERTED ORGANICS INC., 7A COMMERCIAL WHARF WEST, BOSTON MA 02110 |
| Jay Coleman |
director |
310 EAST 46TH ST. APT 9 F, NEW YORK NY 10017 |
| Robert N Fireman |
director |
145 ROSEMARY ST. SUITE H-2, NEEDHAM MA 02494 |
| Worlds.com, Inc. |
director, 10 percent owner, officer: PRESIDENT, CEO, other: TREASURER, SECRETARY |
11 ROYAL ROAD, BROOKLINE MA 02445 |
| Christopher John Ryan |
officer: CFO, VICE PRESIDENT |
11 ROYAL RD, BROOKLINE MA 02445 |
MariMed (MariMed) Headlines
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
MRMD has been successfully added to your